The proportion of CD8+ T-cells was comparable in all conditions, except in the controls which showed a significantly higher presence of CD8+ T-cells compared to BPH (median 79.1% vs. 57.4%, p = 0.002). The gene discussed is CD8A; the disease is benign prostatic hyperplasia.